Anthera Pharmaceuticals Inc (NASDAQ:ANTH)

8.26
Delayed Data
As of Jul 02
 -0.26 / -3.05%
Today’s Change
1.46
Today|||52-Week Range
9.89
+422.78%
Year-to-Date

Today’s Trading

Previous close8.52
Today’s open8.44
Day’s range8.08 - 8.46
Volume454,656
Average volume (3 months)899,202
Market cap$295.8M
Dividend yield--
Data as of 4:00pm ET, 07/02/2015

Growth & Valuation

Earnings growth (last year)+19.53%
Earnings growth (this year)+18.38%
Earnings growth (next 5 years)+78.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
TBRATobira Therapeutics ...+0.27+1.61%
TKAITokai Pharmaceutical...-0.20-1.48%
SNTASynta Pharmaceutical...-0.02-0.91%
--China Health Group I...-0.10-23.81%
Data as of 07/03/2015

Financials

Next reporting dateAugust 4, 2015
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$0.00
Annual profit (last year)-$29.6M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Paul F. Truex
CAO, Senior VP-Finance &
Administration
May Liu
Corporate headquarters
Hayward, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers